Along with our previous study showing that afatinib inhibited OGD-induced neuroinflammation in astrocytes [15], it appears that EGFR-TKIs may be a novel repurposing drug for CNS neurodegenerative diseases, including ICH. The gene discussed is EGFR; the disease is neurodegenerative disease.